IMR Press / EJGO / Volume 37 / Issue 6 / DOI: 10.12892/ejgo3321.2016

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
A retrospective analysis of patients treated for gestational trophoblastic diseases: a 4-year experience of a tertiary hospital
Show Less
1 Department of Obstetrics and Gynecology, Umraniye Medical and Research Hospital, Istanbul, Turkey
2 Department of Obstetrics and Gynecology, Zonguldak Hospital, Zonguldak, Turkey
Eur. J. Gynaecol. Oncol. 2016, 37(6), 817–819; https://doi.org/10.12892/ejgo3321.2016
Published: 10 December 2016
Abstract

Aim: To study incidence, clinical outcome, and follow-up data of the gestational trophoblastic disease (GTD) in patients diagnosed in the present Department. Materials and Methods: This study included the authors' retrospective clinical records regarding the cases of GTD which were diagnosed and followed up between January 2011 and January 2015. Patients' age, gravidity and parity, obstetric history, subgroup of GTD, gestational weeks, management results, and pre-post treatment β-hCG levels was investigated and an incidence study was constituted. Results: Total of 56 GTD cases were hospitalized and clinical records of 16,840 normal spontaneous deliveries were evaluated during the study period. The incidence of GTD was 3.3/1,000 cases. After histopathological examination, nine of 47 cases were partial molar pregnancy, whereas 38 cases were complete moles. There were no choriocarcinoma and invasive moles. All cases were treated with vacuum curettage without complication. Conclusion: The GTD incidence in this clinic is high with a rate of 3.3/1,000 per pregnancy compared to Turkish literature. High birth rates of our population may play a role in high incidence results. Further investigation in this field is essential.
Keywords
Molar pregnancy
β-HCG
Methotrexate
Abortus
Bleeding
Share
Back to top